title: Clinical features and treatment outcomes of infections caused by Sphingomonas paucimobilis.
authors.forename: Hae Suk
authors.initials: HS
authors.lastname: Cheong
authors.forename: Yu Mi
authors.initials: YM
authors.lastname: Wi
authors.forename: Soo Youn
authors.initials: SY
authors.lastname: Moon
authors.forename: Cheol-In
authors.initials: CI
authors.lastname: Kang
authors.forename: Jun Seong
authors.initials: JS
authors.lastname: Son
authors.forename: Kwan Soo
authors.initials: KS
authors.lastname: Ko
authors.forename: Doo Ryeon
authors.initials: DR
authors.lastname: Chung
authors.forename: Nam Yong
authors.initials: NY
authors.lastname: Lee
authors.forename: Jae-Hoon
authors.initials: JH
authors.lastname: Song
authors.forename: Kyong Ran
authors.initials: KR
authors.lastname: Peck
mesh_terms: D000293:Adolescent; D000328:Adult; D000900:Anti-Bacterial Agents / Q000494:pharmacology / Q000627:therapeutic use*; D003428:Cross Infection / Q000188:drug therapy / Q000382:microbiology / Q000503:physiopathology; D005260:Female; D016905:Gram-Negative Bacterial Infections / Q000188:drug therapy / Q000382:microbiology / Q000503:physiopathology; D006785:Hospitals, University; D006801:Humans; D007723:Korea; D008297:Male; D008875:Middle Aged; D020578:Sphingomonas / Q000187:drug effects / Q000472:pathogenicity*; D016896:Treatment Outcome
chemical_list: D000900:Anti-Bacterial Agents